C.M. Bidwell & Associates’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$683K Buy
2,874
+1,677
+140% +$348K 0.28% 59
2026
Q1
$253K Buy
+1,197
New +$258K 0.12% 112
2016
Q1
Sell
-61,270
Closed -$5.47M 263
2015
Q4
$5.47M Sell
61,270
-295
-0.5% -$25.1K 1.3% 20
2015
Q3
$4.73M Sell
61,565
-230
-0.4% -$19.2K 1.16% 25
2015
Q2
$5.17M Buy
61,795
+10
+0% +$883 1.15% 22
2015
Q1
$5.58M Buy
+61,785
New +$5.32M 1.23% 21
2014
Q2
Sell
-72,430
Closed -$5.07M 243
2014
Q1
$5.07M Sell
72,430
-500
-0.7% -$34.8K 1.22% 21
2013
Q4
$4.87M Sell
72,930
-25
-0% -$1.53K 1.21% 20
2013
Q3
$3.81M Hold
72,955
1.05% 28
2013
Q2
$3.44M Buy
+72,955
New +$3.33M 1.01% 40

Other funds holding CAH

C.M. Bidwell & Associates's CAH Position: Q2 2026 in Review

C.M. Bidwell & Associates increased its Cardinal Health (CAH) stake by 140% in Q2 2026, buying an estimated $348K and bringing the position to 2,874 shares worth $683K. The position accounts for 0.28% of the portfolio, ranked #59.

C.M. Bidwell & Associates first reported a position in CAH in Q2 2013 and has held it in 10 quarters since. The position peaked at $5.58M in Q1 2015. 1,498 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • C.M. Bidwell & Associates held 2,874 shares of Cardinal Health worth $683K as of Q2 2026.
  • C.M. Bidwell & Associates bought 1,677 Cardinal Health shares in Q2 2026, an estimated $348K.
  • Cardinal Health made up 0.28% of C.M. Bidwell & Associates's portfolio in Q2 2026, its #59 holding.
  • C.M. Bidwell & Associates first reported a position in Cardinal Health in Q2 2013 and has held it in 10 quarters since.
  • C.M. Bidwell & Associates's Cardinal Health position peaked at $5.58M in Q1 2015.
  • 1,498 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on C.M. Bidwell & Associates's 13F filing for Q2 2026, filed 11 Aug 2026.